People · Operator
Named in public records as an officer, director or promoter · active 2008–2023 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lyndra, Inc. | — | Biotechnology | Series D+ | $281.9M | $1.6B | 2016 |
| Humacyte, Inc. | — | Biotechnology | Series D+ | $274.8M | $6.2B | 2018 |
| Rubius Therapeutics, Inc. | — | Biotechnology | Series D+ | $216.2M | $4.2B | 2017 |
| Frequency Therapeutics, Inc. | — | Biotechnology | Series C | $136.3M | $1.7B | 2019 |
| Tarveda Therapeutics, Inc. | — | Biotechnology | Series B | $127.4M | $141.7M | 2011 |
| Micell Technologies Inc | — | Biotechnology | Series C | $62.1M | $2.5B | 2016 |
| BIND Biosciences Inc | — | Biotechnology | Series B | $51.4M | $345.2M | 2010 |
| Living Proof Inc | — | Other | Series B | $39.0M | $498.4M | 2009 |
| MicroCHIPS, Inc. | — | Biotechnology | Series B | $27.9M | $740.1M | 2015 |
| Predictive Biosciences, Inc | — | Biotechnology | Series B | $26.8M | $1.0B | 2010 |
| Biorez, Inc. | — | Biotechnology | Series A | $25.0M | $89.0M | 2009 |
| EGEN, Inc. | — | Biotechnology | Series A | $18.4M | $141.6M | 2008 |
| Pervasis Therapeutics Inc | — | Biotechnology | Series A | $10.0M | $361.6M | 2009 |
| StemBioSys Inc. | — | Biotechnology | Series A | $9.9M | $43.8M | 2016 |
Robert S Langer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert S Langer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 6 | 36 |
| Peter Barton Hutt | 4 | 14 |
| Michael Greeley | 2 | 15 |
| James Barrett | 2 | 6 |
| Omid Farokhzad | 2 | 4 |
| Robert S. Langer, Jr. | 2 | 3 |
| Omid C. Farokhzad | 2 | 3 |
| Amir H. Nashat | 2 | 3 |
| EDWIN M. KANIA | 2 | 3 |
| Robert Anderson | 1 | 24 |
| Amir Nashat | 1 | 14 |
| Daniel Wagner | 1 | 13 |
| Amy Schulman | 1 | 11 |
| James Wright | 1 | 9 |
| Terrance McGuire | 1 | 9 |
| Noubar Afeyan | 1 | 9 |
| Konstantine Drakonakis | 1 | 8 |
| Timothy J. Barberich | 1 | 7 |
| Scott Minick | 1 | 7 |
| TERRANCE G. MCGUIRE | 1 | 7 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.